Antioxidant status of bilirubin and uric acid in patients with myasthenia gravis

NeuroImmunoModulation

Volumn 19, Issue 1, 2011, Pages 43-49

  Peng, Fuhua ^a   Deng, Xuhui ^a   Zhou, Zhiyang ^a   Jiang, Ying ^a   Yang, Yu ^a   Tan, Feng ^b   Liu, Jia ^a   Gu, Lijia ^a   Hu, Xueqiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Department of Neurology   (China)

Author keywords

Antioxidant; Bilirubin; Myasthenia gravis; Uric acid

Indexed keywords

ANTIOXIDANT; BILIRUBIN; BILIRUBIN GLUCURONIDE; URIC ACID;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; BILIRUBIN; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; URIC ACID; YOUNG ADULT;

EID: 80855147894     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000327727     Document Type: Article

References (27)

1. Pauwels EK, Erba PA, Kostkiewicz M: Anti-oxidants: a tale of two stories. Drug News Perspect 2007; 20: 579-585.
2. Kurien BT, Scofield RH: Autoimmunity and oxidatively modified. Autoimmun Rev 2008; 7: 567-573.
3. Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski H: Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528-2533. (Pubitemid 27136909)
4. Ames BN, Cathcart R, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78:6858-6862. (Pubitemid 12216861)
5. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an anti-oxidant of possible physiological importance. Science 1987; 235: 1043-1046. (Pubitemid 17049750)
6. Wu TW, Carey D, Wu J, Sugiyama H: The cytoprotective effects of bilirubin and bili-verdin on rat hepatocytes and human eryth-rocytes and the impact of albumin. Biochem Cell Biol 1991; 69:828-834.
7. Stuerenburg HJ: The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases. Biochemistry (Mosc) 2000; 65: 862-865.
8. Mecocci P, Fanó G, Fulle S, MacGarvey U, Shinobu L, Polidori MC, Cherubini A, Vecchiet J, Senin U, Beal MF: Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic Biol Med 1999; 26: 303-308. (Pubitemid 29013460)
9. Conti-Fine BM, Milani M, Kaminski HJ: Myasthenia gravis: past, present, and future. J Clin Invest 2006; 116:2843-2854. (Pubitemid 44684466)
10. Brambilla D, Mancuso C, Scuderi MR, Bosco P, Cantarella G, Lempereur L, Di Benedetto G, Pezzino S, Bernardini R: The role of anti-oxidant supplement in immune system, neo-plastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Nutr J 2008; 7:29.
11. Venkatesham A, Sharath Babu P, Vidya Sagar J, Krishna DR: Effect of reactive oxygen species on cholinergic receptor function. J India Pharmacol 2005; 6:366-370. (Pubitemid 43011687)
12. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
13. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-127.
14. Li L, Shou Y, Borowitz JL, Isom GE: Reactive oxygen species mediate pyridostigmine-In-duced neuronal apoptosis: involvement of muscarinic and NMDA receptors. Toxicol Appl Pharmacol 2001; 177:17-25. (Pubitemid 33135210)
15. Li L, Gunasekar PG, Borowitz JL, Isom GE: Muscarinic receptor-mediated pyridostig-mine-induced neuronal apoptosis. Neuro-toxicology 2000; 21:541-552.
16. Halliwell B, Gutteridge JM, Cross CE: Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 1992; 119: 598-620.
17. Drulovic J, Dujmovic I, Stojsavljevic N, Me-saros S, Andjelkovic S, Miljkovic D, Peric V, Dragutinovic G, Marinkovic J, Levic Z, Mostarica Stojkovic M: Uric acid levels in sera from patients with multiple sclerosis. J Neurol 2001; 248: 121-126. (Pubitemid 32245422)
18. Koprowski H, Spitsin SV, Hooper DC: Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol 2001; 49: 139. (Pubitemid 32163024)
19. Madhavan M, Wattigney WA, Srinivasan SR, Berenson GS: Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997; 131: 10 7-113.
20. Ortenblad N, Madsen K, Djurhuus MS: An-tioxidant status and lipid peroxidation after short-term maximal exercise in trained and untrained humans. Am J Physiol 1997; 272:R1258-R1263.
21. Chen J, Tu Y, Connolly EC, Ronnett GV: Heme oxygenase-2 protects against glutathi-one depletion-induced neuronal apoptosis mediated by bilirubin and cyclic GMP. Curr Neurovasc Res 2005; 2:121-131. (Pubitemid 40676620)
22. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH: Bilirubin and glu-tathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 2009; 106:5171-5176.
23. Kirkby K A, Adin C A: Products of heme ox y-genase and their potential therapeutic applications. Am J Physiol Renal Physiol 2006; 290:F563-F571. (Pubitemid 43724956)
24. Davison A, Tibbits G, Shi ZG, Moon J: Active oxygen in neuromuscular disorders. Mol Cell Biochem 1988; 84: 199-216. (Pubitemid 19027109)
25. Mancuso C, Bates TE, Butterfield DA, Calafato S, Cornelius C, De Lorenzo A, Dinkova Kostova AT, Calabrese V: Natural antioxi-dants in Alzheimer's disease. Expert Opin Investig Drugs 2007; 16: 1921-1931.
26. Whitton PS: Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 2007; 150:963-976. (Pubitemid 46628616)
27. Drisko JA: The use of antioxidants in transmissible spongiform encephalopaties: a case report. J Am Coll Nutr 2002; 21:22-25. (Pubitemid 34123705)